| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/23/2006 | US20060040262 Novel compositions and methods in cancer |
| 02/23/2006 | US20060040250 G-protein coupled receptor fusion protein is modified to include one or more sets of serine/threonine clusters, which enhance binding of such GPCR to arrestin; screening for GPCR ligands, agonists and/or antagonists |
| 02/23/2006 | US20060039928 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/23/2006 | US20060039924 Peptide having modified arginine residue; detecting autoimmune antibodies against rheumatoid arthritis |
| 02/23/2006 | US20060039919 an E7 peptide sequence of human papillomavirus type 16, a translocation peptide and a peptide within a carboxyl terminal fragments, used for inhibiting urogenital cancers induced or caused by HPV type 16 |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039915 P-cadherin as a target for anti-cancer therapy |
| 02/23/2006 | US20060039912 Antibodies to adipose tissues |
| 02/23/2006 | US20060039909 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 02/23/2006 | US20060039905 Galectin 11 |
| 02/23/2006 | US20060039884 Baldness related gene and the polypeptide encoded thereby , and uses |
| 02/23/2006 | US20060039861 For magnetic resonance imaging (MRI); peptide modified at its N- and its C-termini, independently, with a moiety comprising a metal chelate complex; specific binding affinity for fibrin; sufficient half-life in vivo |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | CA2576083A1 Protein production method utilizing yebf |
| 02/23/2006 | CA2575368A1 Cloning and expression of recombinant adhesive protein mefp-1 of the blue mussel, mytilus edulis |
| 02/22/2006 | EP1627919A1 An infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 02/22/2006 | EP1627888A1 Antibody and use thereof |
| 02/22/2006 | EP1627886A1 Polypeptide, cDNA encoding the same, and use of them |
| 02/22/2006 | EP1627884A1 Process for producing dipeptides |
| 02/22/2006 | EP1627059A2 Recombinant comamonas testosteroni 5-mgam-4d; amids and carboxylic acid production |
| 02/22/2006 | EP1627058A2 Bioreactor containing cells expressing glycosyltransferase nucleic acids |
| 02/22/2006 | EP1626981A2 Dipeptidyl-peptidase protected proteins |
| 02/22/2006 | EP1626755A2 Intravenous delivery of polynucleotides to cells in mammalian limb |
| 02/22/2006 | EP1276881B1 Methods for enhancing the expression of a protein of interest by recombinant host cells |
| 02/22/2006 | EP1062336B1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 02/22/2006 | EP0805871B2 Anti-cd30 antibodies preventing proteolytic cleavage and release of membrane-bound cd30 antigen |
| 02/22/2006 | EP0729297B1 Hepatoblasts and method of isolating same |
| 02/22/2006 | EP0656060B1 Androgen regulation with dna sequences of rat probasin gene |
| 02/22/2006 | EP0549615B1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 02/22/2006 | CN1738908A Diagnosis of sepsis or SIRS using biomarker profiles |
| 02/22/2006 | CN1738646A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection |
| 02/22/2006 | CN1737157A Method for simultaneously producing bean starch and plant separation protein using endogenous proteinase |
| 02/22/2006 | CN1243021C Interleukin-18 binding proteins, their preparation and use |
| 02/22/2006 | CN1243017C Tumor suppressor, coded protein and application thereof |
| 02/22/2006 | CN1242810C Drug composition, its preparation method and use |
| 02/22/2006 | CN1242809C Applications of T-BAM (CD40L) technology in preparation of medicine to treat diseases involving smooth muscle cell |
| 02/21/2006 | US7002057 Thioredoxin H homologs |
| 02/21/2006 | US7001998 Nucleic acids encoding a chimeric glycosyltransferase |
| 02/21/2006 | US7001997 A metalloprotease having a proteolytic activity; treating various diseases such as diabetic nephropathy, glomerulonephritis, fibrosis, cirrhosis, osteopetrosis and herniated disk; drug screening kits |
| 02/21/2006 | US7001995 Synthetic human papillomavirus genes |
| 02/21/2006 | US7001994 Coupling monosaccharide into glucoprotein |
| 02/21/2006 | US7001986 Fluorescent proteins |
| 02/21/2006 | US7001980 Monoclonal antibodies directed against the G3BP protein, and uses |
| 02/21/2006 | US7001769 modulating cellular senescence in vitro by introducing a polynucleotide (gDNA or cDNA) encoding an amphiphysin-1 protein; genetic engineering; genetic disorders, premature aging |
| 02/21/2006 | US7001764 Compositions comprising tissue specific adenoviral vectors |
| 02/21/2006 | US7001757 Protein |
| 02/21/2006 | US7001751 PyrF gene and the utilization thereof |
| 02/21/2006 | US7001746 Identifying a peptide secreted from a differentiated human adipocyte which involves incubating human preadipocytes in a medium of glucose, a cyclic AMP inducer, a glucocorticoid, insulin, and a PPAR gamma agonist or a RXR agonist |
| 02/21/2006 | US7001745 Preparing a target protein with a carboxy-terminal thioester by producing a target protein fused to an intein and selectively cleaving the fusion with mercaptoethanesulfonic acid; semi-synthetic method of cytotoxic protein synthesis for example |
| 02/21/2006 | US7001744 Gene encoding an antigenic determinant of Escherichia coli is connected to a nontoxic cholera toxin A2 and B subunits (CTXA2B) gene of Vibrio cholerae; chimeric protein is useful as oral vaccine against uropathogenic E. coli with mild side effects |
| 02/21/2006 | US7001743 Nucleotide sequences coding polypeptide for use in controlling cell enlargement in plants |
| 02/21/2006 | US7001742 Human uncoupling protein 3 |
| 02/21/2006 | US7001734 Process for identifying para cation channel modulators |
| 02/21/2006 | US7001732 RIP3 associated cell cycle protein |
| 02/21/2006 | US7001731 Antibody specific for a chemokine receptor; immunoassay and kits |
| 02/21/2006 | US7001729 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 02/21/2006 | US7001599 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/21/2006 | US7001597 Methods for altering fertility |
| 02/21/2006 | US7001595 For therapy of rheumatoid arthritis, inflammation, respiratory diseases, allergy |
| 02/21/2006 | CA2216609C Production of antibodies using cre-mediated site-specific recombination |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/21/2006 | CA2032381C Viral agent |
| 02/17/2006 | CA2573130A1 Isolated fungal promoters and gene transcription terminators and methods of protein and chemical production in a fungus |
| 02/16/2006 | WO2006017853A2 Mutant interleukin-15-containing compositions and suppression of an immune response |
| 02/16/2006 | WO2006016558A1 Novel strains belonging to the genus paenibacillus and method of controlling plant disease by using these strains or culture thereof |
| 02/16/2006 | WO2005115433A3 Methods for cyclizing synthetic polymers |
| 02/16/2006 | WO2005111226A3 Characterization of mcra subunits and uses thereof |
| 02/16/2006 | WO2005095624A3 Filamentous fungal mutants with improved homologous recombination efficiency |
| 02/16/2006 | WO2004096992A3 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 02/16/2006 | WO2004078936A3 Methods for preventing gluconoylation of proteins |
| 02/16/2006 | WO2004078777A3 Dipeptidyl-peptidase protected proteins |
| 02/16/2006 | WO2003033720A8 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 02/16/2006 | WO2003025129A3 Neurotransmission-associated proteins |
| 02/16/2006 | US20060037093 Transgenic transchromosomal rodents for making human antibodies |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060036083 Ribosylated human neutrophil peptide-1or an ADP-ribosylated human neutrophil peptide-1; modified antimicrobial activity compared to alpha defensin lacking ADP-ribosylated or ribosylated residue; altered chemotaxis of T cells, altered neutrophil recruitment |
| 02/16/2006 | US20060036082 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained |
| 02/16/2006 | US20060036079 Surface protein of Leptospira |
| 02/16/2006 | US20060036078 Fluorescent proteins |
| 02/16/2006 | US20060036074 Bromodomain protein |
| 02/16/2006 | US20060035856 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035855 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035835 Novel protein, production and use thereof |
| 02/16/2006 | US20060035813 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 02/16/2006 | US20060035786 use of a polypeptide with the biological activity of sucrose-6-phosphate phosphatase which, if not present, brings about growth retardation symptoms and chlorotic leaves; method for identifying herbicidal or growth-regulatory compounds which inhibit the enzyme; herbicides or growth regulators |
| 02/16/2006 | US20060035366 Transglutaminase-producing strain |
| 02/16/2006 | US20060035363 Novel acylase gene |
| 02/16/2006 | US20060035362 Novel human hydrolase family members and uses thereof |
| 02/16/2006 | US20060035361 Novel cellulase tolerant to surfactants |
| 02/16/2006 | US20060035360 Thermostable DNA polymerases and methods of making same |
| 02/16/2006 | US20060035359 Survivin-binding proteins, encoding nucleic acids, and methods of use |
| 02/16/2006 | US20060035352 Production of 3-hydroxycarboxylic acid using nitrilase |
| 02/16/2006 | US20060035347 Polynucleotides encoding polypeptides involved in amino acid biosynthesis in Methylophilus methylotrophus |
| 02/16/2006 | US20060035340 Fermenting an appropriate microorganism using glucose as a carbon source and operating two chromatographic separation steps wherein ion exchange chromatography is followed by hydrophobic interaction chromatography, wherein the diphtheria toxin has a purity of at least 98%. |
| 02/16/2006 | US20060035339 IL-8 like protein |
| 02/16/2006 | US20060035338 Method and apparatus for the production of soluble MHC antigens and uses thereof |
| 02/16/2006 | US20060035337 Leukocyte adhesion inhibitor-1 polypeptide for use in the treatment of cancer, tumors, chronic infections, leukemia, T-cell mediated auto-immune diseases, parasitic infections, psoriasis, asthma, allergy, to regulate hematopoiesis, to stimulate growth factor activity, to inhibit angiogenesis |
| 02/16/2006 | US20060035336 Prokaryotic collagen-like proteins and uses thereof |
| 02/16/2006 | US20060035335 Use of HCV proteins |
| 02/16/2006 | US20060035334 Apo-2 receptor |